Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCQ908A (Pradigastat) as Add-on to Metformin in Type 2 Diabetes
NCT00901979Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2009
- Primary completion
- Jun 2010
- Countries
- 5
01
Overview
A Phase 2 trial of pradigastat in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Apr 2009; status: completed.
02
Drugs
pradigastat
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00901979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00901979.